Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb 7;6(2):e004328.
doi: 10.1161/JAHA.116.004328.

Serum N1-Methylnicotinamide is Associated With Coronary Artery Disease in Chinese Patients

Ming Liu  1   2 , Jihong Chu  3 , Yang Gu  1 , Haibo Shi  1 , Rusheng Zhang  1 , Lingzhun Wang  1 , Jiandong Chen  1 , Le Shen  1 , Peng Yu  1 , Xiaohu Chen  1 , Wenzheng Ju  4 , Zhenxing Wang  5
Affiliations

Serum N1-Methylnicotinamide is Associated With Coronary Artery Disease in Chinese Patients

Ming Liu et al. J Am Heart Assoc. .

Abstract

Background: We previously reported that serum N1-methylnicotinamide (me-Nam), an indicator of nicotinamide N-methyltransferase activity, is associated with obesity and diabetes mellitus in Chinese patients. However, whether nicotinamide N-methyltransferase plays a role in human coronary artery disease (CAD) remains to be elucidated. We aim to investigate the associations of serum me-Nam with CAD in Chinese patients.

Methods and results: Serum me-NAM was measured by liquid chromatography-mass spectrometry in patients with (n=230) or without (n=103) CAD as defined by coronary angiography. The severity of CAD was expressed by number of diseased coronary arteries. Serum me-Nam was higher (7.65 ng/mL versus 4.95 ng/mL, P<0.001) in patients with CAD than in those without. Serum me-Nam was positively correlated with high-sensitivity C-reactive protein and negatively correlated with high-density lipoprotein before and after adjustment for potential confounding variables (P≤0.002). In multivariable logistic regression analyses, compared with those in the lowest tertile of serum me-NAM levels, patients in the top tertile had the highest risks for CAD (odds ratio, 4.21; 95% CI, 1.97-8.97 [P<0.001]). After adjustment for potential confounding variables, serum me-NAM was also increased from 0- to 3-vessel disease (P for trend=0.01).

Conclusions: Serum me-Nam is strongly associated with presence and severity of CAD, suggesting nicotinamide N-methyltransferase as a potential target for treating atherosclerosis in humans.

Keywords: N1‐methylnicotinamide; coronary angiography; coronary artery disease; inflammation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Association between serum N 1‐methylnicotinamide (me‐NAM) and severity of coronary artery disease (CAD). The analysis was adjusted for age, sex, body mass index, systolic blood pressure, current smoking and alcohol intake, hypertension, diabetes mellitus, dyslipidemia, use of antihypertensive, antihyperglycemic and hypolipidemic drugs, and fasting plasma glucose, total and high‐density lipoprotein (HDL) cholesterol, and triglycerides. The P value for test for trend of the changes of serum me‐NAM concentrations across the severity of coronary angiography is given. *P<0.01 vs normal. **P<0.001 vs normal.
See this image and copyright information in PMC

References

    1. Aksoy S, Szumlanski CL, Weinshilboum RM. Human liver nicotinamide N‐methyltransferase. cDNA cloning, expression, and biochemical characterization. J Biol Chem. 1994;269:14835–14840. - PubMed
    1. Riederer M, Erwa W, Zimmermann R, Frank S, Zechner R. Adipose tissue as a source of nicotinamide N‐methyltransferase and homocysteine. Atherosclerosis. 2009;204:412–417. - PubMed
    1. Shai I, Stampfer MJ, Ma J, Manson JE, Hankinson SE, Cannuscio C, Selhub J, Curhan G, Rimm EB. Homocysteine as a risk factor for coronary heart diseases and its association with inflammatory biomarkers, lipids and dietary factors. Atherosclerosis. 2004;177:375–381. - PubMed
    1. Kraus D, Yang Q, Kong D, Banks AS, Zhang L, Rodgers JT, Pirinen E, Pulinilkunnil TC, Gong F, Wang YC, Cen Y, Sauve AA, Asara JM, Peroni OD, Monia BP, Bhanot S, Alhonen L, Puigserver P, Kahn BB. Nicotinamide N‐methyltransferase knockdown protects against diet‐ induced obesity. Nature. 2014;508:258–262. - PMC - PubMed
    1. Kannt A, Pfenninger A, Teichert L, Tonjes A, Dietrich A, Schon MR, Kloting N, Bluher M. Association of nicotinamide‐N‐methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1‐methylnicotinamide, with insulin resistance. Diabetologia. 2015;58:799–808. - PMC - PubMed

Publication types

MeSH terms